Abstract
The practice of pharmacoeconomics is growing. Companies are responding to government policies on drug pricing by increasing the resources allocated to this discipline. Being a reasonably new area, there are still a number of teething problems, some of which were addressed at the 6th IMS European Symposium held in Brussels, Belgium, in November.
Rights and permissions
About this article
Cite this article
Higgins, G. Getting it right. Inpharma Wkly. 917, 7 (1993). https://doi.org/10.2165/00128413-199309170-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199309170-00015